LEADER 01357cam--2200385---450- 001 990003447530203316 005 20101001110900.0 010 $a978-88-240-1164-8 035 $a000344753 035 $aUSA01000344753 035 $a(ALEPH)000344753USA01 035 $a000344753 100 $a20100930d2010----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $aa---||||001yy 200 1 $aMonumenti antichi, fortezze medievali$eil riutilizzo degli antichi monumenti nell'edilizia aristocratica di Roma (VIII-XIV secolo)$fAlbert Di Santo$gappendice di Sandro Carocci 210 $aRoma$cLibreria dello Stato, Istituto poligrafico Zecca dello Stato$d2010 215 $a190 p.$cill.$d28 cm 606 0 $aMonumenti$xRestauro$yRoma$zSec. 8.-14.$2BNCF 676 $a720.945632 700 1$aDI SANTO,$bAlberto$0608676 702 1$aCAROCCI,$bSandro 801 0$aIT$bsalbc$gISBD 912 $a990003447530203316 951 $aXII.2.A. 686$b227310 L.M.$cXII.2.A.$d00282788 959 $aBK 969 $aUMA 979 $aPASSARO$b90$c20100930$lUSA01$h1133 979 $aPASSARO$b90$c20100930$lUSA01$h1135 979 $aPASSARO$b90$c20100930$lUSA01$h1139 979 $aANNAMARIA$b90$c20101001$lUSA01$h1107 979 $aANNAMARIA$b90$c20101001$lUSA01$h1109 996 $aMonumenti antichi, fortezze medievali$91108772 997 $aUNISA LEADER 07989nam 2200529 450 001 9910555042503321 005 20220328114019.0 010 $a1-118-97597-9 010 $a1-118-97599-5 010 $a1-118-97607-X 035 $a(CKB)4330000000007808 035 $a(MiAaPQ)EBC6577246 035 $a(Au-PeEL)EBL6577246 035 $a(OCoLC)1249473528 035 $a(EXLCZ)994330000000007808 100 $a20211210d2021 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aHandbook of diabetes /$fRudy Bilous, Richard Donnelly, Iskandar Idris 205 $a5th ed. 210 1$aHoboken, New Jersey :$cWiley Blackwell,$d[2021] 210 4$d©2021 215 $a1 online resource (307 pages) 311 $a1-118-97604-5 327 $aCover -- Title Page -- Copyright Page -- Contents -- Preface -- Key to the boxes -- List of abbreviations -- Part 1 Introduction to diabetes -- Chapter 1 Introduction to diabetes -- Further Reading -- Chapter 2 History of diabetes -- Further Reading -- Chapter 3 Diagnosis and classification of diabetes -- Intermediate categories of hyperglycaemia: Pre-diabetes -- Classification of diabetes -- FURTHER READING -- Chapter 4 Public health aspects of diabetes -- Primary prevention of Type 2 Diabetes -- Providing access to structured diabetes education -- Improving diabetes treatment and care -- Commissioning diabetes services -- Further Reading -- Chapter 5 Normal physiology of insulin secretion and action, and the incretin effect -- Islet structure and function -- Insulin synthesis and insulin polypeptide structure -- Insulin secretion -- The incretin effect -- Insulin receptor signalling -- The family of GLUT transporters -- Further Reading -- Chapter 6 Epidemiology and aetiology of type 1 diabetes -- Introduction -- Epidemiology -- Aetiology -- Genetics -- Environmental and maternal factors -- Viruses -- Apoptosis -- Dietary factors -- Toxins -- Animal models -- Hygiene hypothesis -- Accelerator hypothesis -- Further Reading -- Chapter 7 Epidemiology and aetiology of type 2 diabetes -- Prevalence rates and global burden -- Urban versus rural -- Impaired glucose tolerance -- Incidence -- Risk factors for type 2 diabetes -- Conclusion -- FURTHER READING -- Chapter 8 Other types of diabetes -- Introduction -- Monogenic Diabetes and association with other Inherited Conditions -- Other monogenic causes -- Pancreatic disease -- Diabetes complicating other endocrine diseases -- Medication associated diabetes -- Further Reading -- Part 2 Metabolic control and complications -- Chapter 9 Diabetes control and its measurement -- Introduction. 327 $aCapillary blood glucose monitoring -- Urine glucose monitoring -- Glycated haemoglobin -- IFCC standard -- Estimated average glucose (eAG) -- Glucose variability -- Fructosamine -- Urine and blood ketone measurements -- Continuous glucose monitoring (CGM) systems -- Further Reading -- Chapter 10 Management of type 1 diabetes -- Insulin replacement -- Intensive insulin therapy -- Diet and Carbohydrate counting -- Glycaemic targets -- Continuous subcutaneous insulin infusion -- Further Reading -- Chapter 11 Management of type 2 diabetes -- FURTHER READING -- Chapter 12 Diabetic ketoacidosis (DKA), hyperglycaemic hyperosmolar state (HHS) and lactic acidosis -- Precipitating factors for diabetic ketoacidosis -- Pathophysiology -- Treatment -- Complications of diabetic ketoacidosis -- Hyperosmolar hyperglycaemic state -- Lactic acidosis -- Further Reading -- Chapter 13 Hypoglycaemia -- FURTHER READING -- Chapter 14 Causes of complications -- Hyperglycaemia -- Blood pressure -- Metabolic memory -- How does hyperglycaemia cause tissue complications? -- Further Reading -- Chapter 15 Diabetic eye disease -- Pathology and clinical appearances -- Factors associated with the development of retinopathy -- Classification of retinopathy -- Treatment of retinopathy -- Surveillance and screening -- Further Reading -- Chapter 16 Diabetic nephropathy -- Natural history -- Stages of nephropathy -- Epidemiology -- Screening for nephropathy -- Pathology and pathophysiology -- Risk factors for nephropathy -- Management -- Is it diabetic nephropathy? -- Further Reading -- Chapter 17 Diabetic neuropathy -- Chronic sensorimotor neuropathy -- Further Reading -- Chapter 18 Blood lipid abnormalities -- Further reading -- Chapter 19 Hypertension in diabetes -- Causative links -- Definition of hypertension and targets -- Diagnosis of hypertension -- Management -- FURTHER READING. 327 $aChapter 20 Macrovascular disease in diabetes -- Atherosclerosis -- Glycaemic vascular injury -- FURTHER READING -- Chapter 21 Foot problems in diabetes -- FURTHER READING -- Chapter 22 Sexual problems in diabetes -- FURTHER READING -- Chapter 23 Gastrointestinal problems in diabetes -- Symptoms -- Oesophagus -- Gastroparesis -- Small bowel -- Large bowel -- Abdominal pain -- Gut microbiota -- Further Reading -- Chapter 24 Non-alcoholic liver disease (NAFLD) -- Introduction -- Definition -- Risk factors for NAFLD -- NAFLD and diabetes -- Screening -- Management -- Thiazolidinediones -- Glucagon-like peptide-1 analogs and DPP-4 inhibitors -- Sodium Glucose cotransporter 2 inhibitors -- Vitamin E -- Bariatric surgery -- Statins -- FURTHER READINGS -- Chapter 25 Diabetes and cancer -- Introduction -- Epidemiology -- Possible biological mechanisms -- Effect of diabetes on cancer mortality and treatment -- Effects of cancer therapy on diabetes -- Effects of diabetes therapies on cancer incidence and progression -- FURTHER READING -- Chapter 26 Skin and connective tissue disorders in diabetes -- Diabetic dermopathy -- Necrobioisis lipoidica diabetocorum -- Acanthosis nigricans -- Diabetic bullae -- Granuloma annulare -- Skin thickening, waxy skin, and stiff joints -- Other skin conditions -- FURTHER READING -- Chapter 27 Psychological and psychiatric problems in diabetes -- Depression and anxiety -- Diabetes distress -- Cognitive changes -- Severe Mental Illness -- Published guidance. -- FURTHER READING -- Part 3 The spectrum and organisation of diabetes care -- Chapter 28 Intercurrent situations that affect diabetes control -- Exercise -- Drugs -- Infections -- Enteral feeding -- Surgery and critical intercurrent illness -- FURTHER READING -- Chapter 29 Pregnancy and diabetes -- Effects of pregnancy on the woman with diabetes. 327 $aEffects of maternal diabetes on the pregnancy -- Management of pregnancy in diabetes -- Gestational diabetes -- Contraception -- FURTHER READING -- Chapter 30 Diabetes in childhood and adolescence -- FURTHER READING -- Chapter 31 Diabetes in old age -- FURTHER READING -- Chapter 32 Diabetes and lifestyle -- Introduction -- Smoking -- Alcohol -- Drug and substance abuse -- Driving -- Employment -- Travel and leisure activities. -- FURTHER READING -- Chapter 33 Organisation of diabetes care: integrating diabetes service -- What is integrated diabetes care? -- What are the essential components to an integrated diabetes service? -- Impact of COVID-19 pandemic: lessons on organizing diabetes care -- FURTHER READING -- Chapter 34 Transplantation and stem cell therapy -- Pancreas transplantation -- Islet cell transplantation -- Xenotransplantation -- Stem cell therapy -- Gene therapy -- Index -- EULA. 606 $aDiabetes 606 $aDiabetes$xComplications 608 $aElectronic books. 615 0$aDiabetes. 615 0$aDiabetes$xComplications. 676 $a616.462 700 $aBilous$b Rudy W.$0932373 702 $aDonnelly$b Richard$f1960- 702 $aIdris$b Iskandar 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910555042503321 996 $aHandbook of diabetes$92816770 997 $aUNINA LEADER 00895cam0-2200325---450 001 990004365630403321 005 20230830144648.0 010 $a3-7705-3418-2 035 $a000436563 035 $aFED01000436563 035 $a(Aleph)000436563FED01 035 $a000436563 100 $a19990604d2001----km-y0itay50------ba 101 0 $ager 102 $aDE 105 $ay-------001yy 200 1 $a<>Kulturgeschichte der Kulturwissenschaft$fFriedrich Kittler 205 $a2. verbesserte Aufl. 210 $aMünchen$cFink$d2001 215 $a260 p.$d22 cm 610 0 $aCiviltà$aStoria 676 $a901.9 700 1$aKittler,$bFriedrich$0165849 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990004365630403321 952 $a901 KITF 01$b11175 DFM$fFLFBC 959 $aFLFBC 996 $aKulturgeschichte der Kulturwissenschaft$9261100 997 $aUNINA